-
2025-524376-36-00
short-term treatment of insomnia 2
-
2024-512300-19-00
Fahr's disease 4
-
2024-516335-27-00
anti-MAG neuropathy 5
-
2024-513292-40-00
Multiple sclerosis 5
-
2025-522140-40-00
multiple sclerosis 4
-
2024-519235-42-00
Patients with confirmed multiple sclerosis (MS), with w 4
-
2025-523570-17-00
Parkinson's Disease 4
-
2025-524511-36-00
Neurology 4
-
2025-523597-17-00
Painful diabetic peripheral neuropathy 4
-
2025-524564-38-00
Neuropsychiatric indications and potentially other cond 3
-
2024-511880-27-00
Newly diagnosed Glioblastoma (IDH wild-type) patients a 4
-
2023-504690-21-00
This is a study in healthy volunteers. We will study t 3
-
2024-520414-21-00
Adult patients with a LVOS with large core within 9 hou 5
-
2025-524602-15-00
Neurology 4
-
2023-510374-13-00
People with acute ischemic stroke (AIS) due to large ve 5
-
2024-515107-19-00
Patients (male or female) ≥18 years old with Detrusor o 5
-
2024-516383-28-01
Microprolactinomas 5
-
2025-521628-31-00
Friedreich’s ataxia is the most common inherited ataxia 5
-
2023-504696-24-00
Glioma (diffuse astrocytoma, oligodendroglioma or gliob 7
-
2025-524673-16-00
Autism spectrum disorder 4
-
2024-513365-39-00
idiopathic hypersomnia 4
-
2024-517304-12-00
Mechanical allodynia 4
-
2024-517310-15-00
Parkinson's Disease 3
-
2025-521113-13-00
Early Parkinson’s Disease 10